• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Canada

Welcome to the international HTA database


Showing [3276 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: mild traumatic brain injury, knowledge update in preparation for the revision of the ministerial orientations for mild traumatic brain injury (2005-2010)]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: surgical treatment of the esophagus - quality and accessibility in Quebec]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: strategies to optimize the appropriateness of MRI and CT requests - strategies and tools for optimal use]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: a profile of the practices adopted in Quebec to facilitate the transition to adulthood of young people who reside in an alternative living facility]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: cardiopulmonary resuscitation (CPR) in a context of community-based naloxone administration for opioid overdose]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: optimal service trajectory for children, adolescents and young adults with attention deficit disorder with or without hyperactivity (ADHD) or related problems]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: equitable access to the psychotherapy services in Quebec]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of the prostate-specific antigen (PSA) test in prostate cancer screening in Québec]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: the use of EndoPredict and Prosigna for early invasive breast cancer]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: portrait of opioid use in persons covered by Québec’s public prescription drug insurance plan]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: islet transplantation in patients with unstable type I diabetes]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: blepharitis]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: herpes simplex eye disease]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: ministerial standards of access, quality, continuity, efficiency and effectiveness of the service d’intervention de crise dans le milieu 24/7]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: regulation of private congregate living facilities for the elderly]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: living environment quality in long-term care facilities for dependent seniors]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: national and international practices in the organization of rehabilitative care for adults with permanent or temporary motor disabilities]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: best practices for runaway prevention and intervention for youths living in rehabilitation centres for young persons with adjustment problems]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards, English version updated in June 2020: requirements relating to the institutions responsible for the operation of acute healthcare facilities designated within the Quebec trauma network]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge on organizational models for intensive care units]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: antibiotic prophylaxis during clean orthopedic surgery in children and adults]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Flashglucose monitoring system (Freestyle Libre, Abbott), report updated April 8 2020]
2018     Health Quality Ontario (HQO) Structured Education and Neuromuscular Exercise Program for Hip and/or Knee Osteoarthritis: A Health Technology Assessment
2018     Health Quality Ontario (HQO) Magnetic Resonance-Guided Focused Ultrasound Neurosurgery for Essential Tremor: A Health Technology Assessment
2018     Health Quality Ontario (HQO) Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment
2018     Health Quality Ontario (HQO) Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment
2018     Health Quality Ontario (HQO) Bilateral Cochlear Implantation: A Health Technology Assessment
2018     Health Quality Ontario (HQO) Electronic Monitoring Systems to Assess Urinary Incontinence: A Health Technology Assessment
2018     Health Quality Ontario (HQO) Continuous monitoring of glucose for Type 1 diabetes: OHTAC recommendation
2018     Health Quality Ontario (HQO) Portable ultraviolet light surface-disinfecting devices for prevention of hospital-acquired infections: OHTAC recommendation
2018     Health Quality Ontario (HQO) Continuous monitoring of glucose for Type 1 Diabetes: a health technology assessment
2018     Health Quality Ontario (HQO) Portable ultraviolet light surface-disinfecting devices for prevention of hospital-acquired infections: a healthtechnology assessment
2017     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Home use of a mechanical cough-assist insufflation-exsufflation device for adults with neuromuscular diseases who do not require ventilatory support]
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Dialysis modalities for the treatment of end-stage kidney disease: a health technology assessment
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) New drugs for type 2 diabetes: second-line therapy - science report
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Proton beam therapy for the treatment of cancer in children and adults: a health technology assessment
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Dual antiplatelet therapy following percutaneous coronary intervention: a review of the clinical impact of treatment duration
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatments for locally advanced oropharyngeal cancer: a systematic review of clinical effectiveness and cost-effectiveness
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Interventions for the treatment of obstructive sleep apnea in adults: a health technology assessment
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening for hepatitis C virus: a systematic review
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report and optimal usage guide: immunoglobulins in neurology]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report on optimal antipsychotic use and the nonpharmacological management of the behavioural and psychological symptoms of dementia in people with major neurocognitive disorders living in residential and long-term care centers]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Portraits describing pharmacological and non-pharmacological interventions for attention deficit hyperactivity disorder (ADHD) in Quebecers 25 years of age and under]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of introducing a pathogen inactivation process for labile blood products in Quebec]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: organization of the continuum and provision of services to children aged 2 to 9 years with specific language impairment]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: update of proton radiation therapy indications in oncology]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: maintaining a stockpile of influenza antivirals in preparation for a flu pandemic]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal usage guide: cellulitis in adults and children]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: fibrinolysis in ST-segment elevation acute myocardial infarction]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge in support of the decision to integrate new endobronchial ultrasound (EBUS) services in Québec hospitals]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: comparison of cervical cancer screening strategies involving the human papillomavirus screening test (HPV test) or gynecological cytology (Pap test)]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: chemoembolization for unresectable liver metastases according to the primary origin and chemoperfusion for advanced pancreatic cancer]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use, in Québec, of probiotics in the prevention of Clostridium difficile-associated diarrhea in hospitalized patients on antibiotic therapy]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: beta-lactam allergies, assessment of the risk of cross-reactivity with cephalosporins and carbapenems in penicillin-allergic patients]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: statins, lipid-lowering agents and cardiovascular risk reduction]
2017     Institute of Health Economics (IHE) Community paramedicine: program characteristics and evaluation
2017     Institute of Health Economics (IHE) Exploratory brief on glucose monitoring technologies
2017     Institute of Health Economics (IHE) The impacts of public reporting and external benchmarking in cardiac care: A rapid update of the literature
2017     Institute of Health Economics (IHE) Endovascular therapy for acute ischemic stroke
2017     Health Quality Ontario (HQO) Home-based subcutaneous infusion of immunoglobulin for primary and secondary immunodeficiencies: OHTAC recommendation
2017     Health Quality Ontario (HQO) Psychotherapy for major depressive disorder and generalized anxiety disorder: OHTAC recommendation
2017     Health Quality Ontario (HQO) Electrical stimulation for pressure injuries: OHTAC recommendation
2017     Health Quality Ontario (HQO) Retinal prosthesis system for advanced retinitis pigmentosa: OHTAC Recommendation
2017     Health Quality Ontario (HQO) Fibreglass total contact casting, removable cast walkers, and irremovable cast walkers to treat diabetic neuropathic foot ulcers: OHTAC recommendation
2017     Health Quality Ontario (HQO) Psychotherapy for major depressive disorder and generalized anxiety disorder: a health technology assessment
2017     Health Quality Ontario (HQO) Electrical stimulation for pressure injuries: a health technology assessment
2017     Health Quality Ontario (HQO) Retinal prosthesis system for advanced retinitis pigmentosa: a health technology assessment update
2017     Health Quality Ontario (HQO) Fibreglass total contact casting, removable cast walkers, and irremovable cast walkers to treat diabetic neuropathic foot ulcers: a health technology assessment
2017     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of extracorporeal membrane oxygenation for cardiac life support in adult subjects
2017     Technology Assessment Unit of the McGill University Health Centre (MUHC) Plerixafor as first-line choice for stem cell mobilization in non-Hodgkin's lymphoma and multiple myeloma patients
2017     Health Quality Ontario (HQO) Robotic surgical system for radical prostatectomy: OHTAC recommendation
2017     Health Quality Ontario (HQO) Lumbosacral dorsal rhizotomy for spastic cerebral palsy: OHTAC recommendation
2017     Health Quality Ontario (HQO) Left atrial appendage closure device with delivery system: OHTAC recommendation
2017     Health Quality Ontario (HQO) Prolaris cell cycle progression test for localized prostate cancer: OHTAC Recommendation
2017     Health Quality Ontario (HQO) Hyperbaric oxygen therapy for the treatment of diabetic foot ulcers: OHTAC recommendation
2017     Health Quality Ontario (HQO) Percutaneous ventricular assist devices: OHTAC recommendation
2017     Health Quality Ontario (HQO) Robotic surgical system for radical prostatectomy: a health technology assessment
2017     Health Quality Ontario (HQO) Lumbosacral dorsal rhizotomy for spastic cerebral palsy: a health technology assessment
2017     Health Quality Ontario (HQO) Left atrial appendage closure device with delivery system: a health technology assessment
2017     Health Quality Ontario (HQO) Effect of early follow-up after hospital discharge on outcomes in patients with heart failure or chronic obstructive pulmonary disease: a systematic review
2017     Health Quality Ontario (HQO) Prostate cancer patient perspectives on the use of information in treatment decision-making: a systematic review and qualitative meta-synthesis
2017     Health Quality Ontario (HQO) Prolaris cell cycle progression test for localized prostate cancer: a health technology assessment
2017     Health Quality Ontario (HQO) Hyperbaric oxygen therapy for the treatment of diabetic foot ulcers: a health technology assessment
2017     Health Quality Ontario (HQO) Pharmacogenomic testing for psychotropic medication selection: a systematic review of the Assurex GeneSight Psychotropic test
2017     Health Quality Ontario (HQO) Patient safety learning systems: a systematic review and qualitative synthesis
2017     Health Quality Ontario (HQO) Percutaneous ventricular assist devices: a health technology assessment
2017     Health Quality Ontario (HQO) Long-term continuous ambulatory ECG monitors and external cardiac loop recorders for cardiac arrhythmia: a health technology assessment
2016     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Evaluation of technologies allowing the induction of therapeutic hypothermia in patients who have suffered a cardiac arrest]
2016     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Blood conservation strategies in cardiac surgery: the thromboelastogram and rotational thromboelastometer for monitoring hemostasis in cardiac surgery]
2016     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Relevance of adjusting the D-dimer test positivity threshold according to age in patients at low risk of venous thromboembolic events]
2016     Canadian Agency for Drugs and Technologies in Health (CADTH) Anti-vascular endothelial growth factor drugs for the treatment of retinal conditions
2016     Canadian Agency for Drugs and Technologies in Health (CADTH) Monitoring for atrial fibrillation in discharged stroke and transient ischemic attack patients: a clinical and cost-effectiveness analysis and review of patient preferences
2016     Canadian Agency for Drugs and Technologies in Health (CADTH) Capnography for monitoring end-tidal CO2 in hospital and pre-hospital settings: a health technology assessment
2016     Canadian Agency for Drugs and Technologies in Health (CADTH) DNA mismatch repair deficiency tumour testing for patients with colorectal cancer: a health technology assessment
2016     Canadian Agency for Drugs and Technologies in Health (CADTH) Cognitive processing therapy for post-traumatic stress disorder: a systematic review and meta-analysis
2016     Canadian Agency for Drugs and Technologies in Health (CADTH) Point-of-care troponin testing in patients with symptoms suggestive of acute coronary syndrome: a health technology assessment
2016     Institute of Health Economics (IHE) Oxygen therapy in acute care settings
2016     Institute of Health Economics (IHE) Gainsharing and shared savings strategies in the healthcare setting: Evidence for effectiveness
2016     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of biventricular pacing in atrioventricular heart block
2016     Technology Assessment Unit of the McGill University Health Centre (MUHC) Cardiac resynchronization therapy in heart failure